for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioNTech SE - ADR

22UAy.F

Latest Trade

172.00EUR

Change

-7.20(-4.02%)

Volume

15,608

Today's Range

170.10

 - 

179.65

52 Week Range

44.00

 - 

207.90

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Pfizer Says Begins Phase 2/3 Part Of Continuous Study Of The Pfizer-Biontech COVID-19 Vaccine In Healthy Children- Tweet

June 8 (Reuters) - :PFIZER SAYS BEGINS THE PHASE 2/3 PART OF OUR CONTINUOUS STUDY OF THE PFIZER -BIONTECH COVID19 VACCINE IN HEALTHY CHILDREN- TWEET.PFIZER SAYS PHASE 1/2/3 STUDY WILL ENROLL ABOUT 4,500 CHILDREN 6 MONTHS TO 11 YEARS IN US, FINLAND, POLAND, SPAIN AT MORE THAN 90 CLINICAL TRIAL SITES.PFIZER SAYS CHILDREN YOUNGER THAN 6 MONTHS OF AGE MAY SUBSEQUENTLY BE EVALUATED FOR VACCINE TRIAL, ONCE ACCEPTABLE SAFETY PROFILE IS ESTABLISHED. ((Reuters.Briefs@thomsonreuters.com;)).

Bahrain Residents Who Are Over 50, Obese, Have Chronic Illnesses Urged To Get Pfizer Shot Six Months After Their Full Sinopharm Vaccination- WSJ

June 2 (Reuters) - :BAHRAIN RESIDENTS WHO ARE OVER 50, OBESE, HAVE CHRONIC ILLNESSES URGED TO GET PFIZER SHOT SIX MONTHS AFTER THEIR FULL SINOPHARM VACCINATION- WSJ.Further company coverage: [22UAy.DE]. ((Reuters.Briefs@thomsonreuters.com;)).

EMA Endorses Bolstering Pfizer Vaccine Manufacturing Site In Belgium

June 1 (Reuters) - European Medicines Agency (EMA)::SAYS ADDITIONAL MANUFACTURING CAPACITY FOR BIONTECH/PFIZER'S COVID-19 VACCINE.SAYS RECOMMENDED THE APPROVAL OF ADDITIONAL MANUFACTURING AND FILLING LINES AT PFIZER’S VACCINE MANUFACTURING SITE IN PUURS, BELGIUM.SAYS RECOMMENDATION BY CHMP EXPECTED TO HAVE SIGNIFICANT AND IMMEDIATE IMPACT ON SUPPLY OF COMIRNATY IN EUROPEAN UNION.SAYS DECISION REAFFIRMS THAT THE PUURS FACILITY IS CAPABLE OF CONSISTENTLY PRODUCING HIGH-QUALITY VACCINES.

Pfizer And BioNTech To Supply More COVID-19 Vaccine Doses To Europe

May 20 (Reuters) - PFIZER INC <PFE.N>::NEW AGREEMENT TO SUPPLY 900 MILLION DOSES TO EUROPEAN COMMISSION (EC), WITH OPTION TO REQUEST UP TO AN ADDITIONAL 900 MILLION DOSES.ADDITIONAL DOSE DELIVERIES BEGINNING DECEMBER 2021 THROUGH 2023.ALL DOSES FOR EC ARE PLANNED TO BE MANUFACTURED IN EUROPEAN UNION.SAYS PFIZER AND BIONTECH TO SUPPLY EUROPEAN UNION WITH UP TO 1.8 BILLION ADDITIONAL DOSES OF COMIRNATY.BIONTECH CEO SAYS CONTRACT WITH EUROPEAN COMMISSION WILL ENSURE SUFFICIENT DOSES OF COMIRNATY ARE AVAILABLE FOR ALL EU CITIZENS IN 2022 AND 2023.

FDA Authorizes Longer Time For Refrigerator Storage Of Thawed Pfizer-Biontech COVID-19 Vaccine Prior To Dilution

May 19 (Reuters) - FDA: :FDA AUTHORIZES LONGER TIME FOR REFRIGERATOR STORAGE OF THAWED PFIZER-BIONTECH COVID-19 VACCINE PRIOR TO DILUTION, MAKING VACCINE MORE WIDELY AVAILABLE.FDA - AUTHORIZING UNDILUTED, THAWED PFIZER-BIONTECH COVID-19 VACCINE VIALS TO BE STORED IN REFRIGERATOR AT 2°C TO 8°C (35°F TO 46°F) FOR UP TO 1 MONTH.FDA AUTHORIZES LONGER TIME FOR REFRIGERATOR STORAGE OF THAWED PFIZER-BIONTECH COVID-19 VACCINE PRIOR TO DILUTION, MAKING VACCINE MORE WIDELY AVAILABLE.

Health Canada Authorizes More Flexible Storage Conditions For Pfizer-Biontech Covid-19 Vaccine

May 19 (Reuters) - Health Canada::HEALTH CANADA AUTHORIZES MORE FLEXIBLE STORAGE CONDITIONS FOR PFIZER-BIONTECH COVID-19 VACCINE.HEALTH CANADA - AUTHORIZED SUBMISSION FROM PFIZER-BIONTECH TO ALLOW ITS COVID-19 VACCINE TO BE STORED AT REGULAR REFRIGERATED TEMPERATURES (2-8°C) AT POINT OF USE FOR UP TO ONE MONTH..HEALTH CANADA - RECEIVED APPLICATION FROM PFIZER-BIONTECH TO CHANGE STORAGE CONDITIONS OF ITS COVID-19 VACCINE ON MAY 10, 2021.HEALTH CANADA - DETERMINED THAT UNDILUTED PFIZER-BIONTECH COVID-19 VACCINE REMAINS STABLE WHEN STORED AT STANDARD REFRIGERATED TEMPERATURES FOR 31 DAYS.

EMA Extends Approved Storage Period Of Unopened Thawed Pfizer Vaccine Vial To One Month

May 17 (Reuters) - European Medicines Agency::EMA SAYS EMA'S HUMAN MEDICINES COMMITTEE (CHMP) HAS RECOMMENDED A CHANGE TO APPROVED STORAGE CONDITIONS OF COMIRNATY.EMA SAYS CHANGE EXTENDS APPROVED STORAGE PERIOD OF UNOPENED THAWED VIAL AT 2-8°C FROM 5 DAYS TO ONE MONTH.EMA SAYS CHANGE TO APPROVED STORAGE CONDITIONS OF COMIRNATY THAT WILL FACILITATE HANDLING OF VACCINE IN VACCINATION CENTRES ACROSS EUROPEAN UNION (EU).EMA says INCREASED FLEXIBILITY IN STORAGE, HANDLING OF VACCINE EXPECTED TO HAVE A SIGNIFICANT IMPACT ON PLANNING , LOGISTICS OF VACCINE ROLL-OUT IN EU STATES.

Pfizer, Biontech Get First U.S. EUA Of COVID-19 Vaccine In Adolescents

May 11 (Reuters) - Pfizer Inc <PFE.N>::PFIZER AND BIONTECH RECEIVE FIRST U.S. AUTHORIZATION FOR EMERGENCY USE OF COVID-19 VACCINE IN ADOLESCENTS.IN A PHASE 3 TRIAL, VACCINE WAS 100% EFFECTIVE AND GENERALLY WELL TOLERATED IN PARTICIPANTS AGED 12 TO 15 YEARS.PFIZER - DATA ALSO SUBMITTED TO EUROPEAN MEDICINES AGENCY (EMA) AND OTHER GLOBAL REGULATORS, WITH ADDITIONAL AUTHORIZATIONS EXPECTED IN COMING WEEKS.

Biontech Q1 Net Loss Turns To Profit Of EUR 1.13 Billion

May 10 (Reuters) - BIONTECH SE <22UAy.DE>::ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS AND CORPORATE UPDATE.Q1 REVENUES: TOTAL REVENUES WERE ESTIMATED TO BE EUR 2,048.4 MILLION FOR THREE MONTHS ENDED MARCH 31, 2021, COMPARED TO EUR 27.7 MILLION FOR THREE MONTHS ENDED MARCH 31, 2020.Q1 NET PROFIT WAS EUR 1,128.1 MILLION.ON TRACK WITH PREVIOUSLY STATED 2021 FINANCIAL OUTLOOK.

Pfizer Opposes Trips Intellectual Property Waiver For Covid-19 Vaccines

May 7 (Reuters) - Pfizer Inc <PFE.N>::PFIZER OPPOSES TRIPS INTELLECTUAL PROPERTY WAIVER FOR COVID-19 VACCINES.PFIZER INC - UNTIL TODAY, WE HAVE SHIPPED APPROXIMATELY 450 MILLION DOSES OF COVID-19 VACCINE.PFIZER INC SAYS PROPOSED WAIVER FOR COVID-19 VACCINES, THREATENS TO DISRUPT THE FLOW OF RAW MATERIALS.PFIZER - UPON FINALIZATION OF ALL SUPPLY AGREEMENTS, EXPECT THAT 40% OF THEM, OR MORE THAN 1 BILLION VACCINE DOSES, TO GO TO MIDDLE & LOW INCOME COUNTRIES IN 2021.PFIZER - CONCLUDED AGREEMENTS TO SUPPLY 116 COUNTRIES, CURRENTLY IN ADVANCED NEGOTIATIONS WITH MANY MORE FOR TOTAL OF ABOUT 2.7 BILLION VACCINE DOSES IN 2021.PFIZER INC SAYS CO'S INTERNAL TARGET IS TO PROVIDE 3 BILLION DOSES OF COVID-19 VACCINE IN 2021.PFIZER INC - CURRENTLY, RESTRICTION IS THE SCARCITY OF HIGHLY SPECIALIZED RAW MATERIALS NEEDED TO PRODUCE OUR VACCINE.PFIZER CEO SAYS WTO'S PROPOSED WAIVER IS GOING TO "CREATE MORE PROBLEMS".

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up